Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZXH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,467.00 by the Defense Logistics Agency on January 29, 2026, for the supply of Skyrizi 360 mg/2.4 ml on-body applicator units. This firm fixed-price contract, which carries an ultimate completion date of February 20, 2026, was competitively awarded with no set-aside designation. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order exemplifies the operational scope of the DLA's pharmaceutical supply chain, which ensures that military treatment facilities and defense health systems maintain access to essential medications across multiple therapeutic domains. AmerisourceBergen's role as a prime vendor under this expansive IDC reflects its demonstrated capability to efficiently fulfill federal procurement requirements for specialty medications and medical commodities on a competitive basis. The award reinforces the company's strategic position within the federal medical supply network and its ongoing support for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4ZXH?
SPE2DR26F4ZXH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F4ZXH worth?
The government has obligated $12,467 on SPE2DR26F4ZXH.
Is contract SPE2DR26F4ZXH an order under another contract?
Yes. SPE2DR26F4ZXH is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZXH competed?
The extent of competition for SPE2DR26F4ZXH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award